Seeking the Solution to COVID-19 in Border Areas of Thailand: Experts’ Perspectives

Main Article Content

Daniel A Kertesz
Kumnuan Ungchusak
Yong Poovorawan

Abstract

This summarized article is taken from information provided during a panel seminar focused on seeking the solution to coronavirus disease-19 (COVID-19) in the border areas of northern Thailand. World-class health professionals and academics who are working in the field were invited to deliver both information and their perspectives on different aspects of the pandemic. The information is divided into three levels, namely, the global situation and challenges, including further recommendations; the local lessons learned in Thailand and further action and collaborations required of society; and the cutting age research developing COVID-19 vaccines and their implementation and practical recommendations. In conclusion, vaccines are just one of the tools that can be used against the disease, and these vaccines need to be considered as a whole picture, including the prioritization of the administration of vaccines under limited supply, the equity of availability to all people in the world, and the negotiation of affordable prices. Moreover, our traditional prevention and control measures, such as social distancing, face-mask use, and maintenance of personal hygiene, are still strictly recommended.

Article Details

How to Cite
Kertesz, D. A. ., Ungchusak, K. ., & Poovorawan, Y. . (2021). Seeking the Solution to COVID-19 in Border Areas of Thailand: Experts’ Perspectives. Journal of Health Science and Alternative Medicine, 3(1), 1–5. Retrieved from https://he01.tci-thaijo.org/index.php/jhealthscialternmed/article/view/249042
Section
Special Articles

References

Chodick G, Tene L, Patalon T, Gazit S, Tov AB, Cohen D, et al. The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real world evidence. MedRxiv. 2021.DOI: 10.110/2021.01.27.21250612.

Pawlowski C, Lenehan P, Puranik A, Agarwal V, Venkatakrishnan AJ, Niesen MJ, et al. FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. MedRxiv. 2021. DOI: 10.1101/2021.02.15.21251623.

Vasileiou E, Simpson CR, Robertson C, Shi T, Kerr S, Agrawal U, et al. Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland : national prospective cohort study of 5.4 million people. Preprint;1139. DOI: 10.2139/ssrn.3789264.

Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, et al. Coronavirus (COVID-19) Vaccinations - Statistics and Research. https://ourworldindata.org/covid-vaccinations . Published 2020. Accessed April 19, 2021.

Suntronwong N, Thongpan I, Chuchaona W, Budi Lestari F, Vichaiwattana P, Yorsaeng R, et al. Impact of COVID-19 public health interventions on influenza incidence in Thailand. Pathogens and Global Health. 2020 Jul 3;114(5):225-7. DOI: 10.1080/20477724.2020.1777803

Ministry of Transport, Thailand. Transport Accident Management Systems: TRAMS. https://trams.mot.go.th/main-dashboard . Accessed April 19, 2021.

Krammer F. SAR-CoV-2 vaccines in development. Nature. 2020; 586: 516-527.

Milken Institute. COVID-19 Vaccine Tracker. https://www.covid-19vaccinetracker.org. Published 2020. Accessed April 19, 2021.

Polack FD, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. The New England Journal of Medicine. 2020; 383: 2603-2615.